0
0.0
Jul 8, 2024
07/24
by
KNTV
tv
eye 0
favorite 0
quote 0
we've had data in the past the active compound in zepbound and mounjaro, compared to wegovy, it workswe think because of that there's an enhanced effect when it comes to weight loss, not a surprising result, reaffirms findings from previous studies. there's more weight loss with mounjaro and zepbound. >>> coming up, millions of americans are on a mission to tap the fountain of youth, the lengths some people (intercom) flight deck we are go for launch! (ethan) is that the one? (janet) so much space! that open kitchen! (tanya) ...is that a walk in closet? (ethan) i want those tiles! (intercom) boosters engaged. (ethan) wait! we've got a problem! (janet) problem?! (ethan) how can you sell your house when we're stuck on a space station for months???!!! (tanya) no, no! bad timing, janet!!! (janet) but that was the one!!!! (brian) no, no, no... opendoor!! (tanya) don't open the door. (brian) opendoor gives you the flexibility to sell and buy on your timeline. (all) really? (brian) yea!!! (intercom) we have liftoff. (janet) nice! (janet) houston we have a playroom! >>> the saying age before
we've had data in the past the active compound in zepbound and mounjaro, compared to wegovy, it workswe think because of that there's an enhanced effect when it comes to weight loss, not a surprising result, reaffirms findings from previous studies. there's more weight loss with mounjaro and zepbound. >>> coming up, millions of americans are on a mission to tap the fountain of youth, the lengths some people (intercom) flight deck we are go for launch! (ethan) is that the one? (janet)...
0
0.0
Jul 13, 2024
07/24
by
BLOOMBERG
tv
eye 0
favorite 0
quote 0
and rival drugs are already emerging, like zepbound by eli lilly. asked chief executive lars fruergaard jorgensen about regulatory pressures and future growth. so, how do you think about pricing? again, you must have gotten some difficult questions from governments, but also, this goes back to innovation. lars: most products are priced according to the value they bring. and i feel really good about the value of our medicines, what they bring to the individual patient, but also the value to the health care system. and we have, today, health care systems around the world who were typically designed for acute care. but finding that 80% of the cost in the health care system is linked to chronic care. and we have portfolio products that are really addressing some of the chronic diseases of our day and age. diabetes, obesity, and the comorbidities that follow that. we know that there are projections that say, by 2035, the world obesity organization predicts that the cost burden to society will be $4 trillion of people living with obesity. and that cost is
and rival drugs are already emerging, like zepbound by eli lilly. asked chief executive lars fruergaard jorgensen about regulatory pressures and future growth. so, how do you think about pricing? again, you must have gotten some difficult questions from governments, but also, this goes back to innovation. lars: most products are priced according to the value they bring. and i feel really good about the value of our medicines, what they bring to the individual patient, but also the value to the...
0
0.0
Jul 10, 2024
07/24
by
CNNW
tv
eye 0
favorite 0
quote 0
most people have heard about these drugs by now, you know, mounjaro and ozempic and wegovy zepbound. there injectables. and you got to take them once a week. typically, you start at a lower dose and then increase the dose over time. the question about does the weight come back? i mean, right now if you talk to the drug manufacturer's, i think for many of them the expectation is that people might stay on these medications their entire lives. so just think about that. a weekly injection, 52 injections for years and years, decades but what happens if you stop about 50% of people stop and we created this graph to basically show this for you, jim i don't know how well you can see that, but this is true zip-tied, so this would be the manjaro drug as you see, someone taking that 36 weeks, you see the weight comes down pretty significantly ten to 15% of body weight and then if you continue taking it, the way continues to come off, but they gave a placebo and that 36 week point and you did see wait return, although not back to necessarily where they were at the start, the big difference seems
most people have heard about these drugs by now, you know, mounjaro and ozempic and wegovy zepbound. there injectables. and you got to take them once a week. typically, you start at a lower dose and then increase the dose over time. the question about does the weight come back? i mean, right now if you talk to the drug manufacturer's, i think for many of them the expectation is that people might stay on these medications their entire lives. so just think about that. a weekly injection, 52...
0
0.0
Jul 19, 2024
07/24
by
KNTV
tv
eye 0
favorite 0
quote 0
mounjaro or zepbound lost 15.3%. the results do not mean one is better than the other. doctors say both active ingredients are effective and which one is prescribed depends on the needs of the patient. the study comes on the heels of research showing this whole class of weight loss drugs may reduce the risk of certain obesity-related cancers like colon and liver cancer. >>> coming up, how some cities are helping ease the high cost of living by experimenting with a guaranteed income. that's next. did you know... 80% of women are struggling with hair damage? just like i was. dryness and frizz could be damaged hair that can't retain moisture. new pantene miracle rescue deep conditioner, with first-of-its-kind melting pro-v pearls... locks in moisture to repair 6 months of damage in one wash, without weigh down. guaranteed or your money back! for resilient, healthy-looking hair... if you know, you know it's pantene. (♪♪) when life spells heartburn... how do you spell relief? r-o-l-a-i-d-s rolaids' dual-active formula begins to neutralize acid on contact. r-o-l-a-i-d-s spell
mounjaro or zepbound lost 15.3%. the results do not mean one is better than the other. doctors say both active ingredients are effective and which one is prescribed depends on the needs of the patient. the study comes on the heels of research showing this whole class of weight loss drugs may reduce the risk of certain obesity-related cancers like colon and liver cancer. >>> coming up, how some cities are helping ease the high cost of living by experimenting with a guaranteed income....
0
0.0
Jul 8, 2024
07/24
by
KNTV
tv
eye 0
favorite 0
quote 0
while patients taking or zepbound lost 15.3%.e was no difference in the risk of serious side effects. now, the results do not mean one is better than the other. doctors say both active ingredients are effective for weight loss, and which one is prescribed depends on the needs of the patient. now, this study comes on the heels of research showing this whole class of drugs called glp-1s may reduce the risk of obesity-related cancers like colon cancer and liver cancer. >> all right. stephanie gosk, thank you. >>> up next for us, as we continue tonight, what happens when there's too much solar power being produced. the unexpected consequences, next. weathertech products are designed and manufactured in america using only american raw materials. most competitors make things seven thousand miles away... and then wonder why they don't fit. with weathertech in your vehicle you may hear angels singing as you marvel, how do they do it? simple. american technology and american workers deliver quality... not imported junk for a few bucks les
while patients taking or zepbound lost 15.3%.e was no difference in the risk of serious side effects. now, the results do not mean one is better than the other. doctors say both active ingredients are effective for weight loss, and which one is prescribed depends on the needs of the patient. now, this study comes on the heels of research showing this whole class of drugs called glp-1s may reduce the risk of obesity-related cancers like colon cancer and liver cancer. >> all right....
0
0.0
Jul 1, 2024
07/24
by
BBCNEWS
tv
eye 0
favorite 0
quote 0
other similar drugs like mounjaro and zepbound are made by the us pharmaceutical giant eli lilly andoke to its boss and started by asking him how much of an impact these drugs will have on the world. obesity is known and has been shown in surgical intervention studies, but also and lifestyle intervention, when you can mitigate obesity in adulthood, you can mitigate downstream disease and some scale and estimates that 40% of healthcare costs and maybe a little more than that of chronic disease for adults is connected directly to overweight and obesity. of course, heart disease and diabetes, but many others and conditions can be impacted by obesity, and we know that if people can lose weight with diet and exercise, which is always the first line of care and long—term studies in surgical interventions and shorter—term studies, like medicines lily makes, that we can reduce the diseases that are actually downstream of overweight and obesity. if that plays out in medicine by diet and exercise doesn't surgical interventions, we could have a chance to address 40 or 50% of the diseases, which
other similar drugs like mounjaro and zepbound are made by the us pharmaceutical giant eli lilly andoke to its boss and started by asking him how much of an impact these drugs will have on the world. obesity is known and has been shown in surgical intervention studies, but also and lifestyle intervention, when you can mitigate obesity in adulthood, you can mitigate downstream disease and some scale and estimates that 40% of healthcare costs and maybe a little more than that of chronic disease...
0
0.0
Jul 22, 2024
07/24
by
CNBC
tv
eye 0
favorite 0
quote 0
it's kind of stuck here but i think it's got look, the drugs that are like wegovy and mounjaro and zepbounds got what you just described and i don't think it's that expensive given the growth it has. the stock is up 128% for the year which is why it's prone to profit taking but i agree with you, trey. i don't care, double chin, her suit, whatever, you're in good shape. g gloria in indiana. >> hi, jim. my husband and i watched your show for many years but he's dwoen to heaven now. our friend called you and said we need to be more diversified since i have mostly health and tech stocks. what do you think about proctor and gamble? >> i think it's terrific. a lot of times, jeff and i battle back and forth. i was thinking maybe at 169, we ought to sell, but i like it still. it's got a 2.5% yield. 2.3. i just think the proctor, you're not going to go wrong with here. they're doing a lot of great things. maybe get 3, 4% growth. it's terrific. rod in new york. rod. >> hey, jim. it's rod from syracuse. long time club member. >> excellent. >> i'm up 70% this year in my portfolio. thanks for that. >> w
it's kind of stuck here but i think it's got look, the drugs that are like wegovy and mounjaro and zepbounds got what you just described and i don't think it's that expensive given the growth it has. the stock is up 128% for the year which is why it's prone to profit taking but i agree with you, trey. i don't care, double chin, her suit, whatever, you're in good shape. g gloria in indiana. >> hi, jim. my husband and i watched your show for many years but he's dwoen to heaven now. our...
0
0.0
Jul 25, 2024
07/24
by
FBC
tv
eye 0
favorite 0
quote 0
look out novo-nordisk and eli lilly, the makers of wegovy and zepbound have some competition.after it said its advanced experimental weight loss injection into late-stage trial is going earlier than expected. this is joining highly profitable market for glp-1s. gain of 27% for viking. our "countdown closer" says i have a stock that is gaining weight in the category. we have jordan kimmel. which one is it, jordan? >> great to be with you, liz. there is little company, him and hers health. liz: hims and hers health. >>> they advertising is else. they have weight loss in their bag. everyone wants to take a magic pill, forget about eating right, exercising right. hey, man, this is what the public wants and they will pay anything for it. liz: okay. the stock is up about three, a couple of percent here, over one year but the three-year picture is huge, a nice 170% gain. how much more room to run? what else beyond when they offer in that sort of locus of weight loss drugs and weight loss fitness do they have? >> the difference between this and viking too, these guys are profitable th
look out novo-nordisk and eli lilly, the makers of wegovy and zepbound have some competition.after it said its advanced experimental weight loss injection into late-stage trial is going earlier than expected. this is joining highly profitable market for glp-1s. gain of 27% for viking. our "countdown closer" says i have a stock that is gaining weight in the category. we have jordan kimmel. which one is it, jordan? >> great to be with you, liz. there is little company, him and...
0
0.0
Jul 9, 2024
07/24
by
CNNW
tv
eye 0
favorite 0
quote 0
there are zepbound and there is mounjaro. these are all fda approved drugs. semaglutide are the ones that are made by novo nordisk, wegovy, and ozempic. and they are for diabetes and they are also for weight loss now what's interesting is first of all, the semaglutide the way that these medications work as they're all what are called post nutrient hormones. you eat in your body releases hormones to make insulin to tell your brain that you are full and to allow your food actually be digested with the terzepotide. you have two hormones with the semaglutide. you have one hormone known as glp so this study, now, after all, this study was basically trying to figure out which of these drugs work better specifically for weight loss so the study was of some 18,000 people, they went back and looked at medical records between may of 2022 and september of 2023, over a year. and they said which of these work better? and here's the findings. first of all, everybody lost at least 5% away, almost everybody on any drug. but what the terzepotide, again, the manjaro on average
there are zepbound and there is mounjaro. these are all fda approved drugs. semaglutide are the ones that are made by novo nordisk, wegovy, and ozempic. and they are for diabetes and they are also for weight loss now what's interesting is first of all, the semaglutide the way that these medications work as they're all what are called post nutrient hormones. you eat in your body releases hormones to make insulin to tell your brain that you are full and to allow your food actually be digested...
0
0.0
Jul 9, 2024
07/24
by
CNNW
tv
eye 0
favorite 0
quote 0
have heard about them broadly speaking, that the terzepotide and the semaglutide tirzepatide sides are zepbound mounjaro and the semaglutide. and people have heard about even more or wegovy and ozempic the way these drugs work, essentially, they are known as post nutrient hormones jake, every time you eat, your body releases hormones that cause you to make insulin, tells your brain that you are full and slows down your gut so that you can actually digest the food that's essentially how these medications work. what this study was really looking at was how do they stack up in terms of effectiveness? they looked at 18,000 people over about 15:16 months and they compared them essentially, what they found was first of all, most people lost weight just about everybody lost at least 5% of their weight. but at a year, at the year sort of point, the question was, how are people doing then and what they found was that what the terzepotide. and again, that's the medications mounjaro on average, people lost around 15% of their weight whereas with the semaglutide, like the ozempic's around 8% of their weigh
have heard about them broadly speaking, that the terzepotide and the semaglutide tirzepatide sides are zepbound mounjaro and the semaglutide. and people have heard about even more or wegovy and ozempic the way these drugs work, essentially, they are known as post nutrient hormones jake, every time you eat, your body releases hormones that cause you to make insulin, tells your brain that you are full and slows down your gut so that you can actually digest the food that's essentially how these...
0
0.0
Jul 8, 2024
07/24
by
CNNW
tv
eye 0
favorite 0
quote 0
we go v and zepbound. and there are a lot of reasons, unfortunately, when people have to stop, when they don't want to, one is that these can be very expensive and insurance coverage is difficult. another is sometimes people don't like the side effects or can't tolerate them, things like nausea, particularly when you're first starting the drug. these drugs have also been in shortage. they can be very frustrating and hard to find in pharmacies and forth. some people just don't want to take a medicine for the rest of their lives. here's one person's experiences six months after stopping mounjaro that's pretty happy. >> not too long ago to be able to bench press my body weight which is something that i. had never been able to do for a really long time these days, brad olson works out for more than an hour-and-a-half a day. >> he hikes lifts, weights, and he's totally changed how he eats there's really no fast food or restaurant leftovers anymore it's all an effort to maintain the weight he lost taking mounjar
we go v and zepbound. and there are a lot of reasons, unfortunately, when people have to stop, when they don't want to, one is that these can be very expensive and insurance coverage is difficult. another is sometimes people don't like the side effects or can't tolerate them, things like nausea, particularly when you're first starting the drug. these drugs have also been in shortage. they can be very frustrating and hard to find in pharmacies and forth. some people just don't want to take a...
0
0.0
Jul 11, 2024
07/24
by
CNBC
tv
eye 0
favorite 0
quote 0
weight loss pills since not everyone wants to take a shot like novo nordisk week ago or eli lilly's zepboundor more updates when pfizer reports earnings this month. guys? >> angelica, when it comes to pill form, who conceivably is, if there is a leader in terms of developing a pill, is it the leaders already in novo and lilly? >> lilly is the leader here and we're expecting phase three data from them next year. they have a pill that's the furthest along, and pfizer, a little bit ago at the goldman sachs health care conference, was saying they see lilly as the leader, them as next and then astrazeneca. those are separated by a few years, so it is a crowded market, and there is a lead there for lilly, but pfizer still thinks they have a role here. >> definitely trying to play some catch-up today. thank you. angelica peebles. >>> still to come the growth of evs and the ai boom. a look at how some power companies are dealing with this massive surge in demand. >>> coming up on "money movers" this morning former nec director and goldman director gary cohn. we will break down today's cpi number and
weight loss pills since not everyone wants to take a shot like novo nordisk week ago or eli lilly's zepboundor more updates when pfizer reports earnings this month. guys? >> angelica, when it comes to pill form, who conceivably is, if there is a leader in terms of developing a pill, is it the leaders already in novo and lilly? >> lilly is the leader here and we're expecting phase three data from them next year. they have a pill that's the furthest along, and pfizer, a little bit ago...
0
0.0
tv
eye 0
favorite 0
quote 0
now that medications used for weight loss like wegovy and zepbound have been on the market for a while >> i am still on mounjaro for maintenance. >> callie from new jersey started taking mounjaro in july of 2022. when she hit her goal of losing 90 pounds, her focus shifted to maintenance. >> i never want to stop taking these medications. my goal in terms of maintenance is to be on the lowest effective dose possible. i don't ever want to be on a dose that is too high. >> one clinical trial found that patients going off weight loss medications have an average weight gain rebound of about two-thirds of the total weight loss. so many doctors say coming up with a maintenance plan, staying on some amount of medication, may be best for most, but can look different for everyone. >> people are really dialing down these dosages. are they kind of winging it out there? >> some people may be winging it. we recommend that people lose 15% of their body weight or more as a target, and then reduce the dose, take it less frequently. that minimizes the side effects and makes it as cost-effective as possi
now that medications used for weight loss like wegovy and zepbound have been on the market for a while >> i am still on mounjaro for maintenance. >> callie from new jersey started taking mounjaro in july of 2022. when she hit her goal of losing 90 pounds, her focus shifted to maintenance. >> i never want to stop taking these medications. my goal in terms of maintenance is to be on the lowest effective dose possible. i don't ever want to be on a dose that is too high. >>...
0
0.0
Jul 11, 2024
07/24
by
KGO
tv
eye 0
favorite 0
quote 0
the pill's intent is to act similarly as those weekly shots like wegovy and zepbound that suppress appetitefter 50% of the participants reported experiencing side effects like nausea and vomiting. and they stopped taking those pills, by the way. the company deciding to instead channel its efforts into creating a pill patients would only take once a day. pfizer will be developing the pill through the end of the year and will start trials after that to determine the safety and efficacy and tolerability before submitting it to the fda for approval. rebecca? >> so much popularity among these drugs. you can see why they're trying to get one out there, as well. erielle, thank you. we turn now to sports' biggest awards show, the espys. we're going to go back to will reeve in l.a. he's getting ready for it. hey, will. >> hey, rebecca. it's the most glamorous night in sports. superstars and heroes assembled at the dolby theater in the heart of hollywood for the espy awards. running the show for the first time ever, the goat, serena williams. yesterday she shared with me here on "gma" she is nervous
the pill's intent is to act similarly as those weekly shots like wegovy and zepbound that suppress appetitefter 50% of the participants reported experiencing side effects like nausea and vomiting. and they stopped taking those pills, by the way. the company deciding to instead channel its efforts into creating a pill patients would only take once a day. pfizer will be developing the pill through the end of the year and will start trials after that to determine the safety and efficacy and...
0
0.0
Jul 2, 2024
07/24
by
CNBC
tv
eye 0
favorite 0
quote 0
, you can see, are impacting shares of novo nordisk and eli lilly, which makes the weight loss drug zepboundn by 3%. >> meantime, i want to get to our next big guest this hour. joins us to talk markets, crypto, and so much more. galaxy ceo, mike novogratz. mike, it's so good to see you. i want to talk about all of those things, but i want to start with something else, which is politics and this debate. you have been a backer of president biden and i've seen now a tweet that you put out, politicians are narcissists, you write. they even make hedge fund managers look humble. i guess given this lens, it's not that surprising that biden is still running, but damn, it's sad. tell me how you've been thinking over the past week? >> listen, over the last two years, i've literally been saying, we need to move on from this generation. i pledged at one point, no one should vote for anyone over 72. and listen, it was clear as can be in that debate joe biden is too old to run. and people have been saying that for a while. there's been a bunch of people behind the scenes, trying to get something to change
, you can see, are impacting shares of novo nordisk and eli lilly, which makes the weight loss drug zepboundn by 3%. >> meantime, i want to get to our next big guest this hour. joins us to talk markets, crypto, and so much more. galaxy ceo, mike novogratz. mike, it's so good to see you. i want to talk about all of those things, but i want to start with something else, which is politics and this debate. you have been a backer of president biden and i've seen now a tweet that you put out,...
0
0.0
Jul 25, 2024
07/24
by
CNBC
tv
eye 0
favorite 0
quote 0
that includes lilly's zepbound and novo nordisk's wegovy.e who actually have diabetes instead of weight loss. viking plans to begin a phase two study for the oral version of the drug later this year. i'm telling you what still works is you don't eat anything you want to eat. you eat everything you don't want to eat and you will lose weight. you never feel full because you can't have anything you want. you can't have bread, crackers, pa pasta. you can have a little bit of peas, but can't put it on a cracker. >> vegetables? >> you can put it on peppers or something like that. you never feel full. you don't have carbs, you never feel full. >> i found a recipe. cottage cheese on parchment paper and seasons on that. >> my wife has a recipe for bagels that are not made of flour. made of yogurt and everything bagel stuff on it. you bake them. i don't eat cottage. curdled milk. it is like snacks. you don't have to eat that many of them. you need to lose weight -- not you. people in general -- people in general need to lose weight especially as you g
that includes lilly's zepbound and novo nordisk's wegovy.e who actually have diabetes instead of weight loss. viking plans to begin a phase two study for the oral version of the drug later this year. i'm telling you what still works is you don't eat anything you want to eat. you eat everything you don't want to eat and you will lose weight. you never feel full because you can't have anything you want. you can't have bread, crackers, pa pasta. you can have a little bit of peas, but can't put it...